CL241129C100000
- 0.19
- +0.14+280.00%
Colgate-Palmolive Newsroom
DBS Maintains Colgate-Palmolive(CL.US) With Hold Rating, Announces Target Price $104
Colgate-Palmolive: Hold Rating Amid Strong Performance and Limited Upside Potential
BofA Securities Maintains Colgate-Palmolive(CL.US) With Buy Rating
Morgan Stanley Maintains Colgate-Palmolive(CL.US) With Buy Rating, Maintains Target Price $111
A Quick Look at Today's Ratings for Colgate-Palmolive(CL.US), With a Forecast Between $92 to $112
Colgate-Palmolive Is Maintained at Buy by TD Cowen
Colgate-Palmolive Analyst Ratings
Evercore ISI Reaffirms Their Buy Rating on Colgate-Palmolive (CL)
Redburn Atlantic Adjusts Price Target on Colgate-Palmolive to $99 From $94, Maintains Neutral Rating
Sell Recommendation for Colgate-Palmolive Amid Valuation Normalization and Growth Concerns
Colgate-Palmolive: Hold Rating Amid Growth Challenges and Competitive Pressures
Colgate-Palmolive Downgraded to Hold From Buy at Stifel
Morgan Stanley Maintains Colgate-Palmolive(CL.US) With Buy Rating, Maintains Target Price $111
J.P. Morgan Maintains Colgate-Palmolive(CL.US) With Buy Rating, Cuts Target Price to $109
Colgate-Palmolive's Strong Q3 Performance and Growth Potential Justifies Buy Rating
HSBC Adjusts Colgate-Palmolive's Price Target to $99 From $98, Keeps Hold Rating
Nomura Adjusts Colgate-Palmolive (India)'s Price Target to INR3,050 From INR2,800, Keeps at Reduce
RBC Capital Maintains Colgate-Palmolive(CL.US) With Hold Rating, Maintains Target Price $101
Colgate-Palmolive (CL) Gets a Hold From RBC Capital
Goldman Sachs Initiates Colgate-Palmolive(CL.US) With Buy Rating